Oxetine

Quick links to important sections

Oxetine

Treatment option:

Medically reviewed

Laura Arias

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Oxetine

Quick Facts

Property Description
Active Ingredient Paroxetine (as hydrochloride)
Form Tablet / Film-coated oral formulation
Pharmacological Class Selective Serotonin Reuptake Inhibitor (SSRI)
Origin Synthetic
General Purpose Mood stabilization and anxiety management

What is Oxetine and What is its Composition?

Oxetine is a specific, prescription-only pharmaceutical preparation containing the single active ingredient Paroxetine, typically administered as its hydrochloride salt. This drug is a synthetic compound, chemically manufactured, and is supplied as an oral formulation, most commonly a tablet or film-coated tablet. The product's identity is strictly defined by its composition: it is a single-ingredient product whose therapeutic effect is derived exclusively from Paroxetine. This singular focus ensures the medicine is a dedicated psychotropic agent used to manage underlying neurochemical function.

What Type of Medicine is Oxetine (Pharmacological Class)?

Oxetine is scientifically classified as an Antidepressant and, more specifically, belongs to the class of Selective Serotonin Reuptake Inhibitors (SSRIs). Paroxetine's function is to primarily affect the regulation of serotonin. The "selective" nature of the SSRI class is its distinguishing feature, setting it apart from older, less-targeted antidepressants. It operates by focusing its influence on the neurotransmitter serotonin, having only very weak effects on other neurotransmitter systems, a focus that is clinically recognized.

What is the General Purpose of Taking Oxetine?

Paroxetine operates by modulating the serotonergic system. The general purpose of taking Oxetine is to support mood stability and assist in regulating emotional responses by correcting neurochemical activity. By enhancing serotonergic activity, the drug helps to moderate the intensity of emotional states, thereby contributing to the relief of symptoms associated with excessive psychological distress. This action provides a foundation for improved affective and cognitive balance.

Regulatory References

  1. MedlinePlus, NIH

What side effects are possible with Oxetine?

Possible Side Effects and Safety Information: Oxetine

The safety profile of Oxetine (Paroxetine) is structured based on classifications derived from official regulatory documents, detailing observed adverse reactions and specific safety constraints. These effects are formally grouped by frequency and the body system affected, ensuring a neutral communication of risk.


Frequency-Classified Adverse Reactions

The most frequent side effects reported in official documentation fall into the Very Common (ge 1/10) category and include nausea and various forms of sexual dysfunction. Effects classified as Common (ge 1/100 to < 1/10) often affect the Nervous System (e.g., headache, somnolence, dizziness, tremor) and the Gastrointestinal System (e.g., dry mouth, constipation, diarrhea).

Reactions categorized as Rare (ge 1/10,000 to < 1/1,000) include clinically significant events such as the development of Serotonin Syndrome, seizures, and hyponatraemia (low sodium levels in the blood).


Serious Adverse Reactions and Safety Constraints

Official labeling highlights several Serious Adverse Reactions. These include the risk of Suicidal Thoughts and Behavior, particularly in young adults and during the early phases of treatment or following dose adjustments. Other serious, label-documented concerns are Abnormal Bleeding and rare cases of Acute Angle-Closure Glaucoma.

Safety notes also emphasize that certain effects, such as Akathisia (psychomotor restlessness), may be more likely to occur early in treatment or during dose escalation. Furthermore, a range of discontinuation symptoms may appear upon abrupt cessation.


Population-Specific Considerations

Safety documentation notes that older adults may have an increased risk of hyponatraemia and bleeding events. Pediatric use is generally associated with an increased risk of suicidal behavior and hostility. The drug's clearance is affected in patients with severe hepatic or renal impairment, necessitating regulatory consideration.

Overdose and Emergency Response

The official regulatory documents regarding Oxetine (Paroxetine) overdose strictly define specific clinical presentations and mandate immediate emergency action due to the potential for severe systemic complications. Overdose typically results in documented manifestations of excessive serotonergic activity affecting the Central Nervous System, cardiovascular system, and autonomic functions.

Documented overdose presentations include:

  • CNS and Neuromuscular: Agitation, confusion, tremor, seizures, involuntary muscle contractions, and in severe cases, profound coma.
  • Autonomic and Cardiovascular: Tachycardia, sweating, fever, dilated pupils, and critical outcomes like QTc interval prolongation and serious ventricular arrhythmias.

The most critical documented life-threatening outcome is Serotonin Syndrome, which necessitates immediate and intensive supportive measures. Regulatory guidance confirms that no specific antidote is known for Oxetine overdose, meaning management is restricted to being symptomatic and supportive. Specific population notes confirm that patients with hepatic or severe renal impairment face an increased risk of toxicity due to higher plasma concentrations, and hyponatremia has been specifically reported in the elderly population during high exposure events.

When to Seek Help: Immediate medical attention must be sought upon suspicion of an overdose or the onset of severe symptoms. Regulators explicitly state that emergency services must be called immediately if a person collapses, has a seizure, or cannot be awakened.

Therapeutic Uses of Oxetine

Oxetine (Paroxetine) is generally used across key therapeutic domains to provide symptomatic relief and supportive treatment for conditions where emotional or cognitive distress creates symptoms that interfere with daily functioning. The general purpose is to assist in managing symptoms that interfere with daily comfort and anxiety management.

This medicine is commonly used to help with symptom clusters associated with conditions like Major Depressive Disorder (MDD), Generalized Anxiety Disorder (GAD), Panic Disorder, Obsessive-Compulsive Disorder (OCD), Posttraumatic Stress Disorder (PTSD), and Premenstrual Dysphoric Disorder (PMDD).

The medication is applied in addressing situations marked by excessive, persistent worry, sudden episodes of fear, persistent sadness, and disruptive intrusive thoughts. It is often used during phases when symptoms become more noticeable and when supportive symptom management is appropriate.

“This treatment contributes to easing the overall symptom load during periods of heightened symptoms, offering supportive therapeutic benefit.”

The use of Oxetine may help patients cope more steadily with symptom fluctuations and provides supportive relief when symptoms interfere with routine activities.


Quick Fact: Relief for Persistent Emotional and Cognitive Distress

Symptom Domain Type of Relief Provided
Anxiety & Panic Helps ease the burden of chronic apprehension and fear.
Depressive Symptoms Supports general well-being during symptomatic phases against persistent low mood.
Intrusive Thoughts Is relevant for easing disruptive cognitive and behavioral patterns.

Regulatory References

  1. MedlinePlus Drug Information overview

Eligibility and Restrictions for Use

Who Can and Cannot Use This Medicine

Official regulatory documents define eligibility for this medication based on contraindications and specific population criteria.


Populations Who Must Not Use This Medicine (Contraindications)

This medicine is strictly contraindicated (prohibited) for use in patients with:

  • Hypersensitivity: A known allergy or documented hypersensitivity to the drug's active substance or any of its components.
  • Monoamine Oxidase Inhibitors (MAOIs): Concurrent use with, or recent discontinuation of, an MAOI intended to treat psychiatric disorders. A wash-out period (e.g., 5 weeks after stopping this drug before starting an MAOI) is required.
  • Specific Concomitant Medications: Concurrent use with the drugs Pimozide, Thioridazine, Linezolid, or intravenous Methylene Blue.

Eligibility and Population Restrictions

  • Age: Use is not established or is restricted by age. For instance, the drug is not approved for Major Depressive Disorder in children younger than 8 years.
  • Hepatic Impairment: Patients with liver cirrhosis or significant hepatic impairment require special consideration; a lower or less frequent dosage must be used.
  • Pregnancy and Lactation: Use during pregnancy is restricted to cases where the potential benefit justifies the risks. Use is not recommended for mothers who are breastfeeding.

What should I know about interactions with other medicines?

Oxetine (Paroxetine) has officially documented interaction patterns that establish mandatory prohibitions and constraints based on both metabolic and additive pharmacological effects.

Official Contraindicated Combinations

Co-administration is strictly prohibited (contraindicated) with several substances due to high-risk adverse outcomes as defined by regulatory bodies:

  • Monoamine Oxidase Inhibitors (MAOIs): Including the antibiotic Linezolid and intravenous Methylene Blue. This combination is prohibited because of a documented risk of Serotonin Syndrome.
  • Thioridazine and Pimozide: Prohibited because Oxetine is a CYP2D6 enzyme inhibitor and can formally elevate the plasma levels of these drugs, increasing the risk of QTc interval prolongation and serious ventricular arrhythmias.

Pharmacodynamic and Metabolic Interactions

Interaction Type Official Regulatory Statement
Serotonergic Reinforcement Co-administration with other serotonergic agents (e.g., Triptans, Tramadol, St. John’s Wort) is associated with an increased risk of Serotonin Syndrome due to additive activity.
CYP2D6 Substrate Inhibition Oxetine is documented as an inhibitor of the CYP2D6 enzyme. This can lead to elevated plasma concentrations of CYP2D6 substrates, such as Risperidone or Desipramine.
Bleeding Risk Combining Oxetine with oral anticoagulants (e.g., Warfarin) or antiplatelet drugs (e.g., NSAIDs) is formally associated with an increased risk of abnormal bleeding or haemorrhage.

Required Timing and Population Constraints

A mandatory washout period of at least 14 days is required when switching between Oxetine and an MAOI. Additionally, official documents note that subjects with hepatic impairment or severe renal impairment have increased plasma concentrations of Oxetine, suggesting a heightened risk of interaction severity.

Mechanism of Action

How Oxetine Works

Oxetine's mechanism of action is primarily defined by its highly selective blockade of the Serotonin Transporter (SERT), a protein responsible for clearing the neurotransmitter serotonin (5-HT) from the synaptic cleft. This inhibition leads to an immediate increase in available 5-HT, fundamentally enhancing communication within the Central Serotonergic System. This mechanism primarily influences monoamine neurotransmitter pathways, targeting the reuptake process.

Time-Dependent Receptor Adaptation

The sustained elevation of synaptic serotonin initiates a secondary, time-dependent adaptive process in the brain's receptor population. This involves the eventual downregulation and desensitization of key inhibitory autoreceptors (e.g., 5-HT1A). This adaptive process, occurring over several weeks, is necessary to overcome the brain's initial compensatory feedback loops. This biological restructuring establishes a sustained, effective serotonergic signaling pattern, resulting in the functional modulation of neuronal pathways.

Secondary Modulation of Cholinergic Pathways

Oxetine exhibits a secondary, low-affinity antagonistic interaction with various muscarinic acetylcholine receptors. This off-target mechanism extends the drug's activity beyond its primary SERT focus, influencing the cholinergic pathways and distinct physiological effects in systems regulated by the autonomic nervous system.

Dosage and Administration Information

How to Use Oxetine: Administration Guidelines

Oxetine (Paroxetine) is administered exclusively via the oral route, primarily available as immediate-release film-coated tablets, extended-release tablets, and oral suspension. The standard regimen for this medication requires it to be taken as a single daily dose, typically in the morning. The tablets must be swallowed whole and should not be crushed or chewed, a constraint tied to preserving the intended absorption characteristics of the specific formulation. Taking the dose with food is advised to support gastrointestinal tolerance.

Standard Dosing and Administration Protocol

The most common starting dose for immediate-release formulations in adults is 20 mg once daily for most indications, such as Major Depressive Disorder (MDD). Dosage adjustments, if required, are made gradually and cautiously, generally in increments of 10 mg per day at intervals of at least one week. The maximum recommended daily dose for the immediate-release form is usually 50 mg/day for the majority of indications.

Treatment with Oxetine generally involves an initial treatment phase followed by an extended maintenance phase to prevent recurrence of symptoms. Discontinuing the medicine requires a gradual dosage reduction (tapering) over time, as abrupt cessation is generally advised against.

Population-Specific Adjustments

Specific instructions apply to certain populations. For older adults and patients with severe hepatic or renal impairment (creatinine clearance less than 30 mL/min), the recommended initial dose is typically 10 mg per day. For these patient groups, the maximum recommended daily dose is usually limited to 40 mg per day. If a dose is missed, the standard practice is to skip the missed dose and take the next dose at the usual scheduled time, rather than taking a double dose.

Recent Clinical Evidence

Research evidence / Overview of studies for Oxetine

The research base for Oxetine (Paroxetine) consists primarily of Randomized Controlled Trials (RCTs), where study participants are randomly assigned to receive either the medicine or an inactive substitute (placebo). These trials, along with subsequent comprehensive meta-analyses (studies that combine data from multiple trials), contribute to the official evidence record. Research focused on understanding how symptoms change over time and examining patient-reported experiences across specific conditions.


Evidence for use in Mood Stabilization (Major Depressive Disorder)

For Major Depressive Disorder (MDD), researchers primarily focused on short-term (6- to 8-week) RCTs and longer trials up to one year to study the durability of symptom monitoring. These trials examined outcomes related to depression symptom intensity. Studies observed that differences in the reported frequency of participants meeting criteria for a significant symptom change (response) and near-total symptom clearance (remission) were observed between the treatment group and the placebo group in adults. Long-term maintenance studies reported patterns where the frequency of relapse was observed to be different between adult participants who continued treatment and those who received placebo over a period of up to one year.

Evidence for use in Anxiety and Fear Disorders

Oxetine was also studied for Generalized Anxiety Disorder (GAD), Panic Disorder, and Posttraumatic Stress Disorder (PTSD). Research used short-term trials and intermediate-term follow-up for relapse prevention. For GAD, trials reported that differences in outcomes, including measures related to symptom recurrence, were observed between the treatment group and the placebo group over the six-month follow-up period. Pooled analyses reported variations in measured outcomes compared to placebo during the acute phase of PTSD studies.


What is Still Uncertain About Oxetine Research

Official research summarizes what is known — and what is still uncertain. Long-term effects are not fully established for periods extending beyond one year, and the follow-up durations were limited in many pivotal trials. Data for certain groups remain insufficient, particularly for the adolescent population, and regulatory findings have noted that consistent evidence has not been adequately demonstrated for this age group. Also, subgroup findings are uncertain regarding the optimal administration strategy for Premenstrual Dysphoric Disorder (continuous versus intermittent).

Frequently Asked Questions (FAQ)

Common questions about Oxetine (FAQ)

Q: How quickly can a person expect to feel the effects of Oxetine?

A: According to the official product information for medicines in this class, observing a significant change in symptoms often requires patience. Antidepressants generally take several weeks of consistent use before any symptom relief is noted. Monitoring by a healthcare provider is common during the initial months of treatment.


Q: What is the longest timeframe before the full benefit of Oxetine is typically observed?

A: Official information indicates that while many common initial side effects may subside within the first week or two, the period for observing the intended benefit often requires a longer adjustment period. The intended benefit, when observed, may take several weeks after starting treatment, as the body adapts to the sustained changes in signaling.


Q: Is it necessary to have certain tests done while taking Oxetine?

A: Regulatory documents note that this medicine is associated with risks such as low sodium levels in the blood, known as hyponatraemia, and the potential to trigger acute angle-closure glaucoma. For this reason, a healthcare provider may check for these conditions, which could include an eye examination, before prescribing the medication.


Q: Can Oxetine interact with herbal supplements?

A: Official information warns that this medicine should not be taken alongside certain herbal products that also affect serotonin levels, most notably St. John’s Wort. This combination is associated with an increased risk of Serotonin Syndrome, a serious condition caused by excessive serotonin activity. Individuals often discuss the use of other herbal supplements with a healthcare provider.


Q: Are there specific foods or drinks to avoid while taking Oxetine?

A: The product label information suggests discussing the consumption of alcohol with a healthcare provider while using this medicine. Alcohol can potentially increase the nervous system side effects of the drug, such as drowsiness, dizziness, and difficulty concentrating.


Q: Can Oxetine affect blood pressure?

A: While not a common side effect on its own, certain serious adverse events, such as Serotonin Syndrome or overdose, are officially associated with rapid changes in heart function, including a racing heartbeat and fluctuations in blood pressure. The drug's interaction with specific prohibited medicines is also known to increase the risk of abnormal heart rhythm.


Q: What is the half-life of Oxetine according to official drug data?

A: The official Prescribing Information lists the mean elimination half-life of the medicine as approximately 21 hours after a single oral dose. This figure describes the time it takes for half of the dose to be cleared from the body.


Q: Does Oxetine cause weight changes?

A: Official drug labels list decreased appetite as a common adverse reaction observed in clinical trials. Changes in appetite are often a factor in weight fluctuations associated with this type of medicine.


Q: Is it common to feel tired or drowsy when starting Oxetine?

A: Yes, feeling sleepy or having somnolence is explicitly listed as a common adverse reaction in the official prescribing information. This is a common effect observed across many individuals beginning treatment.


Q: Can Oxetine affect sleep patterns?

A: Yes, according to drug information sources, trouble falling asleep or staying asleep, known as insomnia, is listed as a common side effect of this medicine.


Q: Are there any long-term health concerns associated with using Oxetine?

A: Regulatory warnings indicate that the long-term use of SSRI antidepressants, including this medicine, may be associated with a reduced measure of bone strength. This may result in an increased risk of bone fractures, with the risk potentially being higher in older adults.


Q: Can Oxetine be taken with commonly used pain relievers?

A: Official information indicates there is no known concerning interaction between this drug and acetaminophen (a very common pain reliever). However, it is officially associated with an increased risk of bleeding when combined with NSAID pain relievers or aspirin.


Q: Does Oxetine cause dependency?

A: Oxetine is not classified as a controlled substance under the US Controlled Substances Act, which defines drugs with a high risk of abuse or dependency. However, official information notes that abrupt discontinuation is associated with the potential for discontinuation symptoms.


Q: Are there genetic factors that influence how Oxetine works?

A: Regulatory agencies have noted that the body's breakdown and elimination of this drug relies partly on the CYP2D6 enzyme system in the liver. Genetic differences among individuals can affect the function of this enzyme, which may potentially lead to different concentrations of the drug in the body.


Q: Is Oxetine known to cause or worsen anxiety?

A: Nervousness, anxiety, or restlessness is noted in official drug information as a reported side effect. New or worsened anxiety is also listed as a symptom that typically requires monitoring during the initial months of treatment or following dosage changes.


Q: Do the side effects of Oxetine usually go away after a while?

A: Official drug information indicates that many common side effects often improve and may resolve within the first week or two as the body adjusts to the medicine. However, some side effects, such as sexual problems, are noted in regulatory documents as sometimes being persistent and not diminishing over time.


Q: What happens if I accidentally take two doses of Oxetine close together?

A: Official guidance for a missed dose is to skip it and continue the regular schedule. In cases of taking more than the prescribed amount, symptoms of overdose can include agitation, dizziness, headache, and a rapid or irregular heartbeat. Emergency medical attention is required for severe symptoms.


Q: Does taking Oxetine affect my metabolism?

A: Yes, regulatory information states that this medicine is extensively metabolized, primarily by the liver. Its processing is partly handled by the CYP2D6 enzyme system, which can become saturated at the typical clinical doses.


Q: Can Oxetine cause changes in appetite?

A: Official drug labels explicitly list decreased appetite as a common adverse reaction that was observed during clinical trials of the medicine.


Q: What are the official warnings about Oxetine and alcohol consumption?

A: Official drug information and related advisories recommend avoiding or limiting the use of alcohol. The combination can increase the nervous system side effects of the medicine, such as dizziness, drowsiness, and difficulty concentrating.


Q: Is Oxetine considered a controlled substance?

A: Oxetine is not classified as a controlled substance under the US Controlled Substances Act. This indicates that it does not fall into the categories of drugs with a high potential for abuse or dependency.

How should Oxetine be stored and disposed of?

Oxetine (Paroxetine) must be stored and disposed of according to official regulatory requirements to ensure product stability and safety.

Storage Requirements

Condition Requirement (Official Labeled Instructions)
Temperature Store at Controlled Room Temperature, typically 20 C to 25 C (68 F to 77 F).
Protection Keep the medicine protected from light and moisture, and away from excess heat.
Container Store in the original container with the lid tightly closed.
Child Safety Keep out of the sight and reach of children [see NIH/MedlinePlus].

Disposal Instructions

Unused or expired Oxetine should be disposed of using a drug take-back program or mail-back envelope as the preferred method [see FDA guidance]. If a take-back option is unavailable, the medication must not be flushed. Instead, remove the medicine from its original container, mix it with an undesirable substance like dirt or used coffee grounds, place the mixture in a sealed container, and then discard it in the household trash.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Equivalent of Oxetine found in:

A-Z Index: